4/A//SEC Filing
Lecault Veronique 4/A
Accession 0001209191-21-067941
CIK 0001703057other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 5:47 PM ET
Size
10.2 KB
Accession
0001209191-21-067941
Insider Transaction Report
Form 4/AAmended
Lecault Veronique
DirectorChief Technology Officer
Transactions
- Exercise/Conversion
Share Option (right to buy)
2021-11-30+83,333→ 2,774,134 totalExercise: $0.19Exp: 2027-03-23→ Common Shares (83,333 underlying) - Exercise/Conversion
Common Shares
2021-11-30$0.19/sh+83,333$15,833→ 1,422,666 total
Holdings
- 61,580(indirect: By Spouse)
Common Shares
- 7,155,008(indirect: See Footnote)
Common Shares
- 273,630(indirect: See Footnote)
Common Shares
Footnotes (4)
- [F1]The original price was listed as $14.96 which is an administrative error. The correct price is $0.19.
- [F2]These shares are held by Pacific Swell Capital Corp ("Pacific Swell"). The Reporting Person is a director of Pacific Swell and shares voting and dispositive power with respect to the shares held by Pacific Swell. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.
- [F3]These shares are held by Slomo Family Trust. The Reporting Person is a co-trustee of the Slomo Family Trust. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.
- [F4]The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on November 8, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date.
Documents
Issuer
AbCellera Biologics Inc.
CIK 0001703057
Entity typeother
Related Parties
1- filerCIK 0001834418
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 5:47 PM ET
- Size
- 10.2 KB